Cas no 53651-61-9 (Phenol,4-methoxy-2,3,6-trimethyl-)
Phenol,4-methoxy-2,3,6-trimethyl- Chemical and Physical Properties
Names and Identifiers
-
- Phenol,4-methoxy-2,3,6-trimethyl-
- 4-methoxy-2,3,6-trimethylphenol
- 1-methoxy-4-hydroxy-2,3,5-trimethylbenzene
- 2,3,6-trimethyl-4-methoxyphenol
- 3-Hydroxy-6-methoxy-1.2.4-trimethyl-benzol
- 4-Methoxy-2,3,6-trimethyl-phenol
- 4-methoxy-2,5,6-trimethylphenol
- AC1L6RIG
- Methyl-(4-hydroxy-2.3.5-trimethyl-phenyl)-aether
- NSC168489
- SJIRRMZHJWPOCJ-UHFFFAOYSA-N
- 53651-61-9
- DTXSID30304947
- NSC-168489
- 4-Methoxy-2,3,6-trimethylphenol #
- SCHEMBL24407972
- LS-11570
- AKOS022519819
- Phenol, 4-methoxy-2,3,6-trimethyl-
- MFCD24713549
-
- MDL： MFCD24713549
- Inchi： 1S/C10H14O2/c1-6-5-9(12-4)7(2)8(3)10(6)11/h5,11H,1-4H3
- InChI Key： SJIRRMZHJWPOCJ-UHFFFAOYSA-N
- SMILES： O(C)C1=CC(C)=C(C(C)=C1C)O
Computed Properties
- Exact Mass: 166.09942
- Monoisotopic Mass: 166.099379685g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 12
- Rotatable Bond Count: 1
- Complexity: 147
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2
- Topological Polar Surface Area: 29.5?2
Experimental Properties
- PSA: 29.46
- LogP: 2.32600
Phenol,4-methoxy-2,3,6-trimethyl- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| abcr | AB529454-500 mg |
4-Methoxy-2,3,6-trimethylphenol; . |
53651-61-9 | 500MG |
€254.60 | 2022-08-31 | ||
| abcr | AB529454-1 g |
4-Methoxy-2,3,6-trimethylphenol; . |
53651-61-9 | 1g |
€322.50 | 2023-04-17 | ||
| abcr | AB529454-5 g |
4-Methoxy-2,3,6-trimethylphenol; . |
53651-61-9 | 5g |
€907.00 | 2023-04-17 | ||
| abcr | AB529454-500mg |
4-Methoxy-2,3,6-trimethylphenol; . |
53651-61-9 | 500mg |
€269.00 | 2025-04-18 | ||
| abcr | AB529454-1g |
4-Methoxy-2,3,6-trimethylphenol; . |
53651-61-9 | 1g |
€317.00 | 2025-04-18 | ||
| abcr | AB529454-5g |
4-Methoxy-2,3,6-trimethylphenol; . |
53651-61-9 | 5g |
€877.00 | 2025-04-18 | ||
| A2B Chem LLC | BA04114-500mg |
4-Methoxy-2,3,6-trimethyl-phenol |
53651-61-9 | >95% | 500mg |
$467.00 | 2024-04-19 | |
| A2B Chem LLC | BA04114-1g |
4-Methoxy-2,3,6-trimethyl-phenol |
53651-61-9 | >95% | 1g |
$509.00 | 2024-04-19 | |
| A2B Chem LLC | BA04114-5g |
4-Methoxy-2,3,6-trimethyl-phenol |
53651-61-9 | >95% | 5g |
$995.00 | 2024-04-19 | |
| A2B Chem LLC | BA04114-10g |
4-Methoxy-2,3,6-trimethyl-phenol |
53651-61-9 | >95% | 10g |
$1412.00 | 2024-04-19 |
Phenol,4-methoxy-2,3,6-trimethyl- Related Literature
-
Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
-
Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
-
Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
Additional information on Phenol,4-methoxy-2,3,6-trimethyl-
Recent Advances in the Study of Phenol,4-methoxy-2,3,6-trimethyl- (CAS: 53651-61-9) in Chemical Biology and Pharmaceutical Research
Phenol,4-methoxy-2,3,6-trimethyl- (CAS: 53651-61-9) is a phenolic compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its unique methoxy and trimethyl substitutions, has been the subject of various studies exploring its biological activities, synthetic pathways, and therapeutic potentials. The latest research highlights its role as a precursor in the synthesis of bioactive molecules and its emerging significance in drug discovery pipelines.
Recent studies have focused on elucidating the molecular mechanisms underlying the biological activities of Phenol,4-methoxy-2,3,6-trimethyl-. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its inhibitory effects on specific inflammatory pathways, suggesting its potential as an anti-inflammatory agent. The study utilized in vitro assays and molecular docking simulations to identify key interactions between the compound and target proteins, providing a foundation for further drug development efforts.
In addition to its pharmacological properties, advancements in the synthetic chemistry of Phenol,4-methoxy-2,3,6-trimethyl- have been reported. A recent publication in Organic Letters (2024) described an efficient, scalable synthesis route for this compound, employing green chemistry principles to minimize environmental impact. The optimized synthetic protocol achieved a high yield (85%) and purity (>98%), addressing previous challenges in large-scale production.
The compound's potential in oncology research has also been explored. Preliminary findings from a 2024 study indicate that derivatives of Phenol,4-methoxy-2,3,6-trimethyl- exhibit selective cytotoxicity against certain cancer cell lines while showing minimal effects on normal cells. These results, though requiring further validation, open new avenues for the development of targeted cancer therapies with reduced side effects.
Quality control and analytical methods for Phenol,4-methoxy-2,3,6-trimethyl- have seen significant improvements. Recent developments in HPLC and LC-MS techniques now allow for more precise quantification and characterization of this compound and its derivatives, as detailed in a 2023 Analytical Chemistry publication. These methodological advances are crucial for ensuring reproducibility in both research and potential pharmaceutical applications.
Looking forward, researchers are focusing on expanding the therapeutic applications of Phenol,4-methoxy-2,3,6-trimethyl- through structural modifications and formulation development. Several pharmaceutical companies have included this compound in their preclinical pipelines, with particular interest in its potential for treating chronic inflammatory conditions and certain types of cancer. However, challenges remain in optimizing its pharmacokinetic properties and ensuring clinical safety, which will be the focus of ongoing and future research efforts.
53651-61-9 (Phenol,4-methoxy-2,3,6-trimethyl-) Related Products
- 20469-61-8(1-Methoxy-2,3,5-trimethylbenzene)
- 2944-49-2(2,3-Dimethylanisole)
- 62787-18-2(Benzene, 1,2,3,4-tetramethyl-5-(2,3,5-trimethylphenoxy)-)
- 62787-17-1(Benzene, 1-(2,5-dimethylphenoxy)-2,3,4,5-tetramethyl-)
- 14337-37-2(Benzene,3-methoxy-1,2,4,5-tetramethyl-)
- 62787-19-3(Benzene, 1,1'-oxybis[2,3,4,5-tetramethyl-)
- 62787-16-0(Benzene, 1,2,3,4-tetramethyl-5-phenoxy-)
- 35355-33-0(4-Methoxy-2,3-dimethylphenol)
- 34238-76-1(Phenol,2,3,5,6-tetramethyl-4-phenoxy-)
- 39021-83-5(1,4-Dimethoxy-2,3-dimethylbenzene)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
